Quarterly Results Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
259.40
180.26
192.75
137.18
194.97
176.52
170.10
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
259.40
180.26
192.75
137.18
194.97
176.52
170.10
Raw Material Cost
116.28
93.86
106.51
71.33
104.21
97.52
77.45
Purchase of Finished goods
4.73
1.90
1.86
2.27
2.13
5.50
8.38
(Increase) / Decrease In Stocks
-1.45
-9.51
-1.06
0.55
-3.28
7.18
21.89
Employee Cost
24.56
20.83
22.97
20.31
21.16
19.55
21.57
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
51.86
35.66
31.51
27.34
41.75
28.75
33.24
Other Expenses
0.00
0.00
0.00
0.00
0.00
0.00
-0.00
Total Expenditure (Excl Depreciation)
195.98
142.74
161.79
121.80
165.97
158.50
162.53
Operating Profit (PBDIT) excl Other Income
63.42
37.52
30.96
15.38
29.00
18.02
7.57
Other Income
4.95
2.52
1.71
3.41
6.76
2.37
7.93
Operating Profit (PBDIT)
68.37
40.04
32.67
18.79
35.76
20.39
15.50
Interest
0.01
0.01
0.01
0.01
0.01
0.01
0.02
Exceptional Items
0.00
0.00
0.00
0.00
0.00
9.91
0.00
Gross Profit (PBDT)
68.36
40.03
32.66
18.78
35.75
30.29
15.48
Depreciation
6.75
6.56
6.17
6.18
4.71
5.41
6.41
Profit Before Tax
61.61
33.47
26.49
12.60
31.04
24.88
9.07
Tax
14.11
7.89
6.36
3.00
10.04
5.28
5.56
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
47.50
25.58
20.13
9.60
21.00
19.60
3.51
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
47.50
25.58
20.13
9.60
21.00
19.60
3.51
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
47.50
25.58
20.13
9.60
21.00
19.60
3.51
Equity Capital
13.37
13.37
13.37
13.37
13.37
13.37
13.37
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
35.53
19.13
15.06
7.18
15.71
14.66
2.63
Diluted Earnings per share
25.53
19.14
15.06
7.18
15.71
14.66
2.63
Operating Profit Margin (Excl OI)
24.45%
20.81%
16.06%
11.21%
14.87%
10.21%
4.45%
Gross Profit Margin
26.35%
22.21%
16.94%
13.69%
18.34%
17.16%
9.1%
PAT Margin
18.31%
14.19%
10.44%
7.0%
10.77%
11.1%
2.06%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Mar 2026 is 33.05% vs -0.10% in Mar 2025
Consolidate Net Profit
YoY Growth in quarter ended Mar 2026 is 126.19% vs 99.81% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Mar 2026 is 118.69% vs 48.95% in Mar 2025
Interest
YoY Growth in quarter ended Mar 2026 is 0.00% vs -50.00% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025
Compare Quarterly Results Of Venus Remedies With
Figures in Cr
Consolidate Quarterly Results
Change(INR)
Change(%)
Net Sales
259.40
157.11
102.29
65.11%
Other Operating Income
0.00
0.00
0.00
Total Operating income
259.40
157.11
102.29
65.11%
Raw Material Cost
116.28
79.68
36.60
45.93%
Purchase of Finished goods
4.73
6.03
-1.30
-21.56%
(Increase) / Decrease In Stocks
-1.45
0.97
-2.42
-249.48%
Employee Cost
24.56
14.22
10.34
72.71%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
51.86
0.00
51.86
Other Expenses
0.00
17.46
-17.46
-100.00%
Total Expenditure (Excl Depreciation)
195.98
118.36
77.62
65.58%
Operating Profit (PBDIT) excl Other Income
63.42
38.75
24.67
63.66%
Other Income
4.95
1.06
3.89
366.98%
Operating Profit (PBDIT)
68.37
39.81
28.56
71.74%
Interest
0.01
2.89
-2.88
-99.65%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
68.36
36.92
31.44
85.16%
Depreciation
6.75
5.26
1.49
28.33%
Profit Before Tax
61.61
31.67
29.94
94.54%
Tax
14.11
6.36
7.75
121.86%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
47.50
25.31
22.19
87.67%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
47.50
25.31
22.19
87.67%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.00
0.01
-0.01
-100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
47.50
25.30
22.20
87.75%
Equity Capital
13.37
10.38
2.99
28.81%
Face Value
10.00
10.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
35.53
24.37
11.16
45.79%
Diluted Earnings per share
25.53
24.39
1.14
4.67%
Operating Profit Margin (Excl OI)
24.45%
24.66%
0.00
-0.21%
Gross Profit Margin
26.35%
23.50%
0.00
2.85%
PAT Margin
18.31%
16.11%
0.00
2.20%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 259.40 Cr
in Mar 2026Figures in Cr
QoQ Growth in quarter ended Mar 2026 is 43.90% vs -6.48% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 33.05% vs -0.10% in Mar 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 47.50 Cr
in Mar 2026Figures in Cr
QoQ Growth in quarter ended Mar 2026 is 85.69% vs 27.07% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 126.19% vs 99.81% in Mar 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 63.42 Cr
in Mar 2026Figures in Cr
QoQ Growth in quarter ended Mar 2026 is 69.03% vs 21.19% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 118.69% vs 48.95% in Mar 2025
Quarterly - Interest
Interest 0.01 Cr
in Mar 2026Figures in Cr
QoQ Growth in quarter ended Mar 2026 is 0.00% vs 0.00% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 0.00% vs -50.00% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 24.45%
in Mar 2026Figures in %
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025
